-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EQVKAWKvVZBU+ebEK2R9CmPKdMGuLYnJOMA2sNXcATd+20v/7z7OY395LVKaixto Y4q430qQ9I9kVNfoMsb9rQ== 0000789289-95-000030.txt : 19951231 0000789289-95-000030.hdr.sgml : 19951231 ACCESSION NUMBER: 0000789289-95-000030 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19951229 SROS: NONE FILER: COMPANY DATA: COMPANY CONFORMED NAME: BLANCHARD FUNDS CENTRAL INDEX KEY: 0000789289 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 133333918 STATE OF INCORPORATION: MA FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 033-03165 FILM NUMBER: 95606341 BUSINESS ADDRESS: STREET 1: 41 MADSON AVE 24TH FL CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 2127797979 MAIL ADDRESS: STREET 1: 41 MADISON AVENUE 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: BLANCHARD STRATEGIC GROWTH FUND DATE OF NAME CHANGE: 19901225 497 1 THE BLANCHARD GROUP OF FUNDS Blanchard Growth & Income Fund Blanchard Capital Growth Fund NOTICE TO SHAREHOLDERS: The parent company of The Chase Manhattan Bank, N.A., the Portfolio Adviser to the Portfolio in which your Fund invests, has entered into an Agreement and Plan of Merger with Chemical Banking Corporation. This prospectus supplement is to advise you of the intended merger. In 1996, you will be solicited to approve a new investment advisory contract with the new entity. We do not anticipate that there will be any impact on the management of your fund. SUPPLEMENT TO PROSPECTUS DATED AUGUST 7, 1995 In August 1995, The Chase Manhattan Corporation and Chemical Banking Corporation announced that they had entered into an Agreement and Plan of Merger (the "Merger Agreement") pursuant to which The Chase Manhattan Corporation will merge with Chemical Banking Corporation (the "Holding Company Merger"). Under the terms of the Merger Agreement, Chemical Banking Corporation will be the surviving corporation in the Holding Company Merger and will continue its corporate existence under Delaware law under the name "The Chase Manhattan Corporation." Subsequent to the Holding Company Merger, The Chase Manhattan Bank, N.A. (the "Portfolio Adviser"), will be merged with and into Chemical Bank, a New York banking corporation (the "Bank Merger"). Both the Holding Company Merger and Bank Merger are subject to certain conditions, including certain regulatory approvals. As required by the Investment Company Act of 1940, as amended (the "1940 Act"), the current advisory agreement (the "Current Agreement") between the Portfolios in which each Fund is invested, and the Portfolio Adviser, provides for its automatic termination upon its "assignment" (as defined in the 1940 Act). Consummation of the Holding Company Merger and the Bank Merger may be deemed to result in an assignment of each Current Agreement and, consequently, to terminate each Current Agreement in accordance with its terms. After the Holding Company Merger, the Portfolio Adviser (or the successor thereto) will continue rendering services to the Portfolios in which each Fund is invested, under anticipated exemptive relief from the Securities and Exchange Commission and advisory services will not be impaired thereby. Shareholder approval of new advisory agreements will be solicited in the first quarter of 1996. December 29, 1995 FEDERATED SECURITIES CORP. Distributor A subsidiary of FEDERATED RE INVESTORS Federated Investors Tower PITTSBURGH, PA 15222-3779 Cusip 093265304 Cusip 093265403 -----END PRIVACY-ENHANCED MESSAGE-----